SPARK Grants

Frequently Asked Questions

Who is eligible for the grant award?

Clinical, translational and basic researchers with experience in the field of NMOSD and autoimmune diseases, who are affiliated with academic institutions in the United States are encouraged to apply.

How much funding is available?

A maximum of 4 grants up to $25,000 each will be awarded to physicians/scientists to advance research in NMOSD. As part of the application process, investigators are required to outline their plans for the grant funding, and to demonstrate their leadership in patient care and research in NMOSD for consideration by the TSF Grant Committee.

Is the grant awarded to the individual’s institution?

Yes, this award will be granted to an institution.

Who is on the TSF Grant Committee?

Our grants program has an Advisory Committee consisting of members who are external peer reviewers who lend their expertise and time to reviewing and assessing applications for TSF awards. The grant committee has sole decision-making authority in determining the winner and runner-up and will score applications based on predetermined criteria.

Once a grant is awarded, will there be any requirements for the investigator to meet certain milestones or report to TSF?

Yes, the winning team is required to share its outcomes through a report at the mid-term and completion of the project.

Application Instructions and Deadline

In 2020, TSF will be awarding up to grants to applicants. Interested applicants should provide a two-page summary of their project.

Please be sure to include budget information (funding secured & requested), a list of personnel, and a CV.

Applications are to be submitted using the form below by August 31, 2020.  The TSF grant committee will review all applications by September 25, 2020.  

Grant recipients will be acknowledged and checks will be distributed on October 27, 2020.

For more information and/or application instructions, please email